CTRI/2013/02/003380
Completed
未知
A prospective, non-interventional, cohort survey on VTE risk in patients receiving new chemotherapy for cancer - CANTARISK
Sanofi Synthelabo India Ltd0 sites4,300 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: null- Colorectal or Lung (SCLC or NSCLC) cancerHealth Condition 2: C349- Malignant neoplasm of unspecifiedpart of bronchus or lung
- Sponsor
- Sanofi Synthelabo India Ltd
- Enrollment
- 4300
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with:
- •colorectal or lung (SCLC or NSCLC) cancer, cytologically or histologically confirmed,
- •metastatic or locally advanced,
- •and about to start a new chemotherapy
- •Age \>\= 18 years
- •Written informed consent
Exclusion Criteria
- •Patients on:
- •Current or anticipated anticoagulant use with exception of use to maintain patency of central venous catheter only.
- •Life expectancy \< 4 months
- •Patients participating or planned to be enrolled in clinical trials with blinded study therapy
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
An observational, non-interventional cohort study to monitor physical and social activity of bladder cancer patients during treatment with curative intent by using conventional and digital methodologyBladder cancer1003836410004994NL-OMON51316Academisch Medisch Centrum50
Active, not recruiting
Not Applicable
Digital monitoring of bladder cancer patients (eBladder)Bladder cancerCancerISRCTN55744047Amsterdam University Medical Centers50
Active, not recruiting
Not Applicable
The impact of rotavirus vaccine introduction in SAsevere gastroenteritisInfection - Other infectious diseasesACTRN12611000559910Children, Youth and Women's health Service200
Recruiting
Not Applicable
A prospective, descriptive cohort study evaluating the prevalence and incidence of exocrine pancreatic insufficiency in patients with pancreatic cancer.NL-OMON35011Academisch Medisch Centrum50
Not yet recruiting
Not Applicable
A prospective, explorative cohort study to identify biomarkers of treatment response in oropharyngeal cancer.NL-OMON27421Erasmus MC200